Portfolio company
Desentum
Finland
Raised
Undisclosed
Latest stage
Growth
Rounds recorded
3 · 3 undisclosed
Backed by
3 investors
Sectors
About
This biopharmaceutical company develops allergen immunotherapy products to treat patients suffering from respiratory and food allergies.
SourceFunding history · 3
Similar companies
Resistentia Pharmaceuticals AB
This company develops immunotherapeutic products for patients suffering from allergic asthma and inflammatory disorders.
Stallergenes Greer
This biopharmaceutical company develops and manufactures allergen immunotherapy products for healthcare professionals treating patients with respiratory, food, and animal-related allergies.
Alladapt Immunotherapeutics
This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.
Allergios
This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.
Tolergyx
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
ANERGIS SA
Anergis SA develops ultra-fast synthetic vaccines to treat patients suffering from frequent environmental allergies such as birch pollen and house dust mites.
Excellergy Therapeutics
This biotechnology company develops trifunctional effector cell response inhibitors to treat patients with severe allergic diseases by removing bound antibodies from immune cells.
Moonlight Therapeutics
This biotechnology company develops microneedle dermal stamps that deliver allergen immunotherapy to patients suffering from peanut and other food allergies.
